Cargando…
NOS1 inhibits the interferon response of cancer cells by S-nitrosylation of HDAC2
BACKGROUND: The dysfunction of type I interferon (IFN) signaling is an important mechanism of immune escape and metastasis in tumors. Increased NOS1 expression has been detected in melanoma, which correlated with dysfunctional IFN signaling and poor response to immunotherapy, but the specific mechan...
Autores principales: | Xu, Pengfei, Ye, Shuangyan, Li, Keyi, Huang, Mengqiu, Wang, Qianli, Zeng, Sisi, Chen, Xi, Gao, Wenwen, Chen, Jianping, Zhang, Qianbing, Zhong, Zhuo, Lin, Ying, Rong, Zhili, Xu, Yang, Hao, Bingtao, Peng, Anghui, Ouyang, Manzhao, Liu, Qiuzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896289/ https://www.ncbi.nlm.nih.gov/pubmed/31805977 http://dx.doi.org/10.1186/s13046-019-1448-9 |
Ejemplares similares
-
Inhibition of NOS1 promotes the interferon response of melanoma cells
por: Chen, Xi, et al.
Publicado: (2022) -
The role of S-nitrosylation of PFKM in regulation of glycolysis in ovarian cancer cells
por: Gao, Wenwen, et al.
Publicado: (2021) -
NOS1 S-nitrosylates PTEN and inhibits autophagy in nasopharyngeal carcinoma cells
por: Zhu, Lingqun, et al.
Publicado: (2017) -
Publisher Correction: NOS1 S-nitrosylates PTEN and inhibits autophagy in nasopharyngeal carcinoma cells
por: Zhu, Lingqun, et al.
Publicado: (2019) -
The heterocyclic compound Tempol inhibits the growth of cancer cells by interfering with glutamine metabolism
por: Ye, Shuangyan, et al.
Publicado: (2020)